Revisiting influenza A virus life cycle from a perspective of genome balance

por Du, Ruikun, Cui, Qinghua, Chen, Zinuo, Zhao, Xiujuan, Lin, Xiaojing, Rong, Lijun
Publicado 2022

Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL(pro)

por Du, Ruikun, Cooper, Laura, Chen, Zinuo, Lee, Hyun, Rong, Lijun, Cui, Qinghua
Publicado 2021

SARS-CoV-2 cell entry and targeted antiviral development

por Chen, Zinuo, Du, Ruikun, Galvan Achi, Jazmin M., Rong, Lijun, Cui, Qinghua
Publicado 2021

A Parallel Phenotypic Versus Target-Based Screening Strategy for RNA-Dependent RNA Polymerase Inhibitors of the Influenza A Virus

por Zhao, Xiujuan, Wang, Yanyan, Cui, Qinghua, Li, Ping, Wang, Lin, Chen, Zinuo, Rong, Lijun, Du, Ruikun
Publicado 2019

Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategy

por Zhao, Xiujuan, Lin, Xiaojing, Li, Ping, Chen, Zinuo, Zhang, Chengcheng, Manicassamy, Balaji, Rong, Lijun, Cui, Qinghua, Du, Ruikun
Publicado 2022

Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases

por Chen, Zinuo, Cui, Qinghua, Cooper, Laura, Zhang, Pin, Lee, Hyun, Chen, Zhaoyu, Wang, Yanyan, Liu, Xiaoyun, Rong, Lijun, Du, Ruikun
Publicado 2021